Table 4

Unadjusted and adjusted effect of ACS compared between post-ACS and pre-ACS periods on significant outcomes

OutcomesUnadjusted
OR (95% CI)
P valueAdjusted
OR (95% CI)
P value
Mortality rate*0.46 (0.30 to 0.70)<0.0010.54 (0.30 to 0.97)0.040
Overall complications*0.60 (0.39 to 0.91)0.0160.72 (0.43 to 1.21)0.215
Respiratory complications*0.46 (0.27 to 0.77)0.0030.52 (0.29 to 0.96)0.036
Pneumonia*0.30 (0.10 to 0.89)0.0300.29 (0.07 to 1.14)0.076
Respiratory failure*0.51 (0.30 to 0.88)0.0150.63 (0.34 to 1.16)0.138
%EGD*3.44 (2.06 to 5.74)<0.0012.94 (1.67 to 5.19)<0.001
OutcomesUnadjusted
Mean difference (95% CI)
P valueAdjusted
Mean difference (95% CI)
P value
LOS (days)†−0.8 (−1.6 to −0.1)0.033−0.4 (−1.2 to 0.3)0.272
Time to EGD (hours)†−19 (−27 to −11)<0.001−19 (−27 to −10)<0.001
  • Adjusted for age, gender, hemodynamic status, hemoglobin, platelet, international normalized ratio and all comorbidities.

  • *Multiple logistic regression.

  • †Multiple linear regression.

  • %EGD, proportion of patients undergoing esophagogastroduodenoscopy; EGD, esophagogastroduodenoscopy; LOS, length of hospital stay.